Discovery Science Award
Who can apply: Submissions must focus on pediatric cancer, aim to lead to less toxic and more targeted treatments, be communicated in accessible lay language, and demonstrate strong potential to progress toward a clinical trial within 1–3 years. New, ongoing, and updated peer-reviewed research is eligible, but in-progress or ongoing clinical trials are not accepted. Submitting institutions or organizations must be based in the United States. A maximum of two LOIs may be submitted from the same institution, organization, or researcher per award cycle. Conflicts of interest must be disclosed. Indirect or overhead costs may not exceed 15% of the total award.
Deadline: LOI opens October 1 annually and is due November 30; invited full proposals open February 15 and are due March 31; award recipients are notified May 15.